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their mean age was 65±10 years.47% of women were hypertensive, 38% dia-
betic, 21.6% sedentary, 20% postmenopausal and 12.3% obese. 294 patients
(56.05%) were in New York Heart Association class II, 150 (28.7%) in class
III and 18 (3.56%) in class IV. Fifty eight patients (10.9%) with atrial fibrilla-
tion. Heart rate on admission was greater than 80 beats per minute in
255 patients (48.5%). Only 6 patients had preserved systolic function. Heart
failure was ischemic in 47.42% cases, toxic in 4.76% cases, 6 patients had a
peripartum cardiomyopathy. About the treatment only 23.80% of women had
reached the target dose of beta blockers. Women tend to develop heart failure
at an older age and with better left ventricular systolic function compared with
men. Women are more likely than men to have hypertension and diabetes as
underlying risk factors for heart failure and are less likely to have coronary
artery disease. The morbidity associated with heart failure in women is signi-
ficant, but the prognosis is better than in men, since women with heart failure
generally survive longer.
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Echocardiographic data of 1500 patients with chronic heart failure
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Malika Noureddine, Ahmed Bennis
CHU Ibn Rochd, Casablanca, Maroc
Introduction: In patients with chronic heart failure, echocardiography pro-
vides important information on the mechanism of heart failure (HF) and
defining the severity of the disease.
The aim of our study is to identify the echocardiographic characteristics of
patients with chronic heart failure (CHF), and to determine the predictors of
improvement of echocardiographics parameters.
Material And Methods: This was a single centre, observational study. We
included 1578 patients followed for CHF (heart failure which had lasted for
more than 1 year) in Ibn Rochd Center of Cardiology from May 2006 to
October 2010. All patients had a complete Doppler echocardiographic exami-
nation and all parameters were analysed. During follow-up, we defined an
improvement of echocardigraphic parameters by an increase of left ventricular
ejection fraction >5% compared to baseline), change in cardiac filling pres-
sures assessed by Doppler echocardiography from restrictive to non-restrictive
pattern and decrease of RVSP by more than 20% compared to baseline.
Results: The mean age of our patients was 64.82±10.12 years (16-100),
and 64% were men. CHF was due to ischaemic heart disease in 55%. Mean
left ventricular ejection fraction (LVEF; biplane Simpson method) was 35%
(10%-69%). LVEF was 35% in 897 patients (57%), 35%-50% in
505 patients (32%) , and 50% only in 176 patients (11%). Mean Left ven-
tricular end-diastolic diameter (LVEDD) was 58mm (32-89), restrictive mitral
inflow was found in 21% of patients and high LV filling pressures in 30% of
patients. Pulmonary arterial systolic pressure was more than 35mmhg in 22%
of patients. The predictors of improvement in echocardiographic data were
female sex, sinus rhythm and high doses of diuretics.
Conclusion: Echocardiography is well qualified to meet the growing need
for non invasive imaging in the HF population. In fact, Echocardiography pro-
vides important data for therapeutic decision-making and improve the out-
come of patients with CHF.
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Prognosis of heart failure (series of 1500 patients)
Fatima Wadrahmane [Orateur], Salma Fadili, Safae Abderrazak, Nadia
Zoubir
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There are differences between heart failure (HF) of the woman and that of
man in terms of epidemiology, pathophysiology, treatment response and same
quality of care. The prognosis seems to be better in women although the
mechanism is not well understood. Clinical trials of HF include more men
than women which limits our understanding of this disease in women.
Our goal is to analyze the epidemiological profile of women followed by
Heart Failure Therapy Unit (UTIC) in the center of cardiology see how they
are optimized to the therapeutic and prove especially that the female is an
independent prognostic factor.
Our study group is composed of all patients followed at the Heart Failure
Therapy Unit. 1500 patients, between January 2006 and December 2010.
Of the 1500 patients 975 were men and 525 women. The average age for
men was 64±4 years versus 68±4 years for women. 21% of men had diabetes
and 26% hypertensive versus 38% and 47% in women. 28% of men had at
least one coronary lesion confirmed versus 11% in women. Concerning the
treatment 78% of the men was optimized (full dose of beta blocker-ACE
inhibitor conversion- Aldosterone antagonists) versus only 45% among
women. After 1 year of follow up there were 8% of men who died (3.5% of
cardiovascular causes) versus 4.2% among women (1.6% of cardiovascular
causes) (p<0.001).
The results of our study are similar to those of the literature, show that
women with heart failure are treated worse than men and their prognosis is
better than that of men.
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Objective: To investigate the prognostic value of diastolic filling pattern
after cardiac resynchronisation therapy (CRT).
Patients: 29 consecutive patients with heart failure (mean age 66 ±8 years;
ischaemic/non-ischaemic 7/22; New York Heart Association (NYHA) class 3
or 4; left ventricular ejection fraction 25±7%; with an indication for CRT and
demonstrated left ventricular dyssynchrony by echocardiography.
Left diastolic measurements included pulsed-wave Doppler (PWD) –
derived transmitral filling indices (E- and A-wave velocities, E/A ratio, Ewave
deceleration time: DT).
Clinical responders were predefined as patients with improvement by one
or more NYHA functional class and reverse remodelling as reduction of left
ventricular end-systolic volume by 15% or more during follow-up. Mean
follow-up was 8±2 months.
Results: Overall, 26 (89%) were clinical responders to CRT .
The PWD-derived parameters of diastolic function improved significantly
(decreased E-wave velocity and E/A ratio; increased A-wave velocity and DT)
in the clinical responder group without significant changes in the nonre-
sponder group.
Reverse remodelling, occurring in 51%, was coupled to the improvement
in LV diastolic function in all patients. Improvement in diastolic function was
noted in 80% of survivals and only in 20% of died patients (p=0.033).
Conclusions: clinical and echocardiographic responders to CRT improved
significantly their diastolic function. This improvement is significantly more
frequent in survivals.
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Purpose: Arterial hypertension is one of major aetiologies for heart failure.
Large prospective trials demonstrated that treatment of hypertension can
reduce incidence of heart failure, especially in patients with diabetes. the aim
of this study was to evaluate if the management of blood pressure in patients
with chronic heart failure was satisfactory in our pratical.
Methods: We included 1509 patients followed for chronic heart failure for
4 years. We evaluated the blood pressure, the heart rate and pharmacological
treatment.
Results: The mean age was 64.47 years (16-100 years) with male predomi-
nance (58%). The average heart rate was 84.23 beats/min; The mean systolic and
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diastolic blood pressure were 130.14 mmHg and 73.48 mmHg respectively. Inci-
dences of co-morbidities was as follow: ischemic heart disease in 49.3%, arterial
hypertension in 34.12%, diabetes in 28.03%, atrial fibrillation in 9.94% and renal
insufficiency in 8.55%. In 60.7% of patients we measured blood pressure below
140/90 mmHg (mean 116.94/70.4 mmHg) while in 39.9% blood pressure was
higher than 140/90 mmHg (mean 159.89/101.14 mmHg). Average blood pressure
differed significantly (p<0.001) between two groups. There was a significantly dif-
ference on prescript of ACE inhibitors (76.09% vs 57.33%), beta blockers (70.3%
vs 52.78%), calcium channel blockers (4.69% vs 17.02%) and digoxine (2.94% vs
1.68%). Patients with lowest blood pressure were less often treated with furo-
semide (28.33% vs 45.63%, p<0.05) but more often with spironolactone (55.78%
vs 32.37%, p<0.05).
Conclusions: The management of blood pressure in chronic heart failure is
very important and due to an adequate and optimal pharmacological treatment.
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Purpose: Hyperuricemia could be a valid prognostic marker and useful for
metabolic, hemodynamic, and functional staging in chronic heart failure. hyper-
uricemia is associated with deleterious effects on endothelial dysfunction, oxida-
tive metabolism, platelet adhesiveness, hemorheology, and aggregation
Methods: The purpose of this study was to determine association between
hyperuricemia and prognosis in 1509 patients with chronic heart failure,
during median follow-up of 32 months. Chi2 test was used, a difference was
statistically considered significant if p<0.05.
Results: The prevalence of hyperuricemia was 10.73% (162), the mean age
was 64.62 years (37-100) with a male predominance (64.81%). The mean
ejection fraction was 32.47%. Thirty eight percent patients have hypertension
and 21.6% have diabetes. There was a correlation between hyperuricemia and
severity of heart failure compared with normouricemia evaluated by: NYHA
functional class, [75,72% patients with hyperuricemia were in class II vs
61.03% for normouricemia (p= 0.0093), 35,69% in class III vs 25.03%
(p=0.0095) and 4.98% in class IV vs 2.09% (p=0.0091)], renal dysfunction:
mean creatinine was at 16.25 for hyperuricemia vs 11 mg per litr for normou-
ricemia, use of diuretics 61.11% vs 40.46% (p=0.0059), congestive heart
failure in 24.07% vs 12.04% (p=0.0086)
Conclusions: High serum uric acid levels are a strong, independent marker
of impaired prognosis in patients with chronic heart failure
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Background: Heart failure (HF) patients are particularly susceptible to
electrolyte abnormalities and especially to hyperkalemia. Potassium (K) bal-
ance may be lost both through the neurohormonal mechanisms and through
the drugs used in the treatment of this illness. Both hypokalaemia and hyper-
kalaemia are associated with increased mortality, mainly due to a higher risk
of potentially fatal arrhythmia.
Our goal was to explore the incidence and predictors of hyperkalemia in a
broad population of heart failure patients.
Methods: This was a retrospective study of 1371 consecutive patients
admitted to the therapeutic unit for heart failure between May 2006 and Sep-
tember 2010. Patients on dialysis and those with an estimated glomular filtra-
tion rate (GFR)<10ml/min/1,73m² were excluded. Complete history on
admission, age, sex, body weight, physical findings, comorbidities, and labo-
ratory information were collected.
Results: The mean age of our population was 64.4 years (16-100), with a male
predominance (64.6%). In 18 patients (1.3%) K was <3.0 mmol/L, and in 424
patients (30.9%) K was >5.0 mmol/L. Independent of treatment assignment,
patients at highest risk for hyperkalemia were those with age 75 years (28.5%),
diabetes (33.9%), male gender (25.5%), high potassium at baseline (24.5%), renal
dysfunction (44.5%) (identified by creatinine 2 mg/dl or GFR 30 ml/min/1.73m²),
symptomatic HF (28.1%) and those receiving therapy with angiotensin-converting
enzyme (ACE) inhibitors (25.3%) or spironolactone (27.2%).
Conclusion: Changes in potassium ion may cause life-threatening arrhyth-
mias. The risk of hyperkalemia is increased in symptomatic heart failure
patients with comorbidities or combined renin-angiotensin-aldosterone system
(RAAS) blockade. A favorable balance of benefit and risk requires clinical
vigilance and closer laboratory monitoring, particularly among these patients.
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Background: Chronic Heart failure (CHF) has a poor prognosis. Most of right
ventricular (RV) echocardiographic variables measure only basal or annular RV
function. Global 2D strain, is used to detect the first signs of LV dysfunction. Our
hypothesis was that RV-2Dstrain, allowing to measure basal to apical RV lateral
wall systolic function, was lower in CHF than in controls and was a better pre-
dictor of cardiac events in CHF than other RV echo-variables.
Methods: 43 controls and 118 chronic heart failure patients with sinus
rhythm, optimal medication and stabilized at east for one month (CHF) were
prospectively enrolled from November 2005 to April 2008 in our CHF clinic.
All patients had a clinical, biological and echocardiographic assessment. 2D
RV strain and four chamber LV strain, left ventricle and left atria dimensions,
diastolic LV function, tricuspid annular plane excursion, peak systolic velocity
of the tricuspid annular using tissue Doppler imaging were assessed. The pri-
mary endpoint was death or urgent transplantation or ventricular assist device
or an acute heart failure episode.
Results: RV-2Dstrain was measurable in 39 controls (57.5±17.2 years,
50% men) with a median and 95% CI of: –30% (–39%; –20%). RV-2Dstrain
was measurable in 104 CHF, their age and left ventricular ejection fraction
mean +/– SD were 57.0±10.9 years and 28.8±8.2%. 80 % were men. RV-
2Dstrain mean and 95%CI in CHF was –19%(–34%; –9%). Prevalence of RV
dysfunction was 52% in CHF if –20% was used as threshold. During a mean+/
– SD follow-up of 37+/–14 months for the patients without events. 57 patients
reached the primary endpoint. On Cox proportional hazards multivariate anal-
ysis only RV-2Dstrain and logBNP were independent predictor of outcome.
The threshold of RV-2Dstrain defined using ROC curve was –21%. Patients
with RV-2Dstrain >–21% had the worse prognosis (X2-log-Rank test=14,
p<0.0001) than patient with RV-2Dstrain <–21%.
Conclusion: RV 2D strain is a strong independent predictor of outcome in
HF and appears to be superior to the other RV or LV systolic echocardio-
graphic variables.
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Biochemical marker testing has revolutionized the approach to diag-
nosis and management of heart failure (HF). Natriuretic peptides are rou-
tinely used, nevertheless better biomarkers are needed to improve
diagnosis and guide therapy. Applying proteomics to clinical samples from
patients with acute heart failure (AHF), Quiescin Q6 (QSOX1) emerged as
a promising marker to differentiate dyspnea caused by acute decompensated
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